Skip to content

DOKTER JOHN ROOSEN

Active
Private limited companyfounded 2003active for 23 yearsTorteldreef 18, 3140 Keerbergen, BelgiumKBO/BCE: BE 0480.101.203
Summary

DOKTER JOHN ROOSEN has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €377,740 and a net result of €220,878. Equity has been shrinking by about 10% per year since 2018. Its solvency ranks better than 40% of 3,033 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 25-04-2003 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.302.465.145 3140 Keerbergen, since 25-04-2003
Financial year end
31 December
Peppol
Reachable since 24-11-2023

Board and ownership

Board
  • Roosen JohnDirector

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€522,755
▲ 99.9%
Turnover
≈ €1.0m
estimated
Profit
€220,878
▲ 163%
Equity
€377,740
▲ 35.6%
Total assets
€799,101
▲ 99.6%
Score breakdownlowers riskSector: Human health activities (NACE 86)Size: total assets €799,101Liquidity: current ratio 2.00, cash €299,624Figures for financial year 2025 (filed on 23-07-2026)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 56% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 72-23
equity 47.3% of total assets
Liquidity 91+20
short-term debt 19.2% · cash 37.5%
Profitability 85+19
return on assets 27.6%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €35,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.0 (4.07 in 2024), above the usual 1.5. Short-term debt is 19.2% and cash 37.5% of total assets. However, 52.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 38% of them on solvency, 76% on liquidity, 36% on profitability and 74% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €799,101
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 2.00, cash €299,624
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 23-07-2026)
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €377,740
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
8 days early
2024
6 days early
2023
15 days early
2022
35 days early
2021
44 days early
2020
11 days early
2019
43 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 23 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 17 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Result rose in 2025from €84,128 to €220,878 ▲ 163% View
  • Positive: 8th oldest company in Keerbergen, Health and social work sectorin the Checked rankings No. 8 View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View

Recent changes

  1. · Gazette deed Purpose
  2. · Gazette deed Incorporation
All 16 events

Comparable companies

These companies have the same main activity as DOKTER JOHN ROOSEN: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €698,000 and €851,000, founded between 2000 and 2005.

CompanyTotal assetsGross margin
DOKTER JOHN ROOSEN Keerbergen€799,101€522,755
EYECARE Chaumont-Gistoux€786,611€482,037
DOCTEUR THILLE Esneux€757,278€507,459
DR. VAN DOORNE LUC Oostkamp€831,075€482,741
DOKTER CAROLINE CARDYN Knokke-Heist€698,223€558,437
DR. S. POURJAVAN, OOGARTS Zaventem€821,728€408,299
O.D.R.PEDOPSY Seneffe€851,478€453,211
Full comparison

Key facts about DOKTER JOHN ROOSEN

What is the company number of DOKTER JOHN ROOSEN?
The company number of DOKTER JOHN ROOSEN is 0480.101.203. The VAT number is the same number with BE in front: BE 0480.101.203.
Where is DOKTER JOHN ROOSEN based?
The registered office is at Torteldreef 18, 3140 Keerbergen.Company details
What does DOKTER JOHN ROOSEN do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DOKTER JOHN ROOSEN?
The legal form of DOKTER JOHN ROOSEN is Private limited company (BV).
When was DOKTER JOHN ROOSEN founded?
DOKTER JOHN ROOSEN was founded on 25-04-2003.
Is DOKTER JOHN ROOSEN still active?
Yes, DOKTER JOHN ROOSEN is an active enterprise in the KBO register.
What is the turnover of DOKTER JOHN ROOSEN?
The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €522,755 and 40 comparable companies (NACE 862). It probably lies between €680,000 and €1.6m.Financials
Is DOKTER JOHN ROOSEN profitable?
In financial year 2025, DOKTER JOHN ROOSEN made a profit of €220,878.
Where can I find the annual accounts of DOKTER JOHN ROOSEN?
DOKTER JOHN ROOSEN filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DOKTER JOHN ROOSEN due?
DOKTER JOHN ROOSEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.